SCHEMBL8975188

SCHEMBL8975188

CC(COc1ccc(CC2SC(=O)NC2=O)cc1)N1CC(COc2cccc(Cl)c2)OC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.49
MPC2 O95563 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2C9 P11712 1/20 0.46
GRM2 Q14416 1/20 0.45
FFAR1 O14842 11/20 0.45
PPARA Q07869 2/20 0.43
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8975392 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8974643 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8975354 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8974648 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8975359 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8975396 1.00 PPARG (0.49) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8974627 0.92 PPARG (0.47) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8975081 0.92 PPARG (0.47) PPARGMPC2CYP2C8CYP2C9GRM2
SCHEMBL8974634 0.91 FFAR1 (0.49) PPARGMPC2CYP2C8CYP2C9FFAR1
SCHEMBL8974613 0.91 PPARG (0.47) PPARGMPC2CYP2C8CYP2C9GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5578620-A TREATMENT OF DIABETES AND HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1996-11-26 US claimed
US-5578620-A TREATMENT OF DIABETES AND HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1996-11-26 US disclosed
EP-0678511-A2 Thiazolidine and oxazolidine derivatives, their preparation and their medical use SANKYO COMPANY LIMITED (JP) 1995-10-25 EP disclosed